Summary of Expertise, Experience and Affiliations and Interests for the Scientific Advisory Committee on Metabolic and Endocrine Therapies (SAC-MET)

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

Contact: Bureau of Policy, Science and International Programs Enquiries

Related Information: Scientific Advisory Committee on Oncology Therapies - Membership List and Biographies

Purpose of the Summary

The following summarizes the information about expertise or experience, affiliations and interests relevant to the Scientific Advisory Committee on Metabolic and Endocrine Therapies (SAC-MET) mandate declared by committee members. Health Canada considered these declarations as part of the selection process. The Health Products and Food Branch has made this summary available as part of its commitment to be transparent about the membership of its advisory bodies.

Assessment of affiliations and interests prior to each meeting

Prior to each committee meeting, Health Canada assesses members' affiliations and interests, including direct financial interests, as they may apply to agenda items for discussion. Depending on the nature of the member's affiliations or interests, the Chair of the committee in consultation with the members, may limit the participation of a member in the meeting or ask him/her to make a verbal statement of affiliations and interests at the beginning of the meeting. Members' affiliations and interests are reviewed on an annual basis and updated as required based on changes in the status of their affiliations and interests.

In accordance with the Health Products and Food Branch Review of Regulated Products: Policy on Public Input and Guidance on Advisory Bodies, a person with a direct financial interest in the outcome of a review of a regulated product may be a member of an advisory body whose broader mandate encompasses matters of policy, management, or program development. However, such a member would not be asked to participate in any discussion, formulation of advice, or recommendations to Health Canada relating to that review.

Indicated Sector/Perspective and Expertise/Experience

Sector/perspective:

• Health professional
• Research
• Academia
• Patient/Consumer

Expertise/experience:

• Endocrinology (adult and paediatric)
• Metabolism
• Internal medicine
• Pharmacokinetics
• Gastroenterology
• Basic and applied pharmaceutical / biological sciences and technologies
• Patient interest groups
• Biostatistics/epidemiology
• Bioethics
• Cardiology
• Family medicine
• Immunology
• Medical biochemistry
• Molecular Biology
• Pathology
• Pharmacology
• Pharmacy

1. Direct financial interests

1. Current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares or bonds, with the regulated industry

2. Indirect financial interests

1. Within the past five years, payment from regulated industry for work done or being done, including past employment, contracts or consulting; or financial support including research support, personal education grants, contributions, fellowships, sponsorships, and honoraria¹
2. Within the past five years, materials, discounted products, gifts, or other benefits, or attendance at meetings where all or part of the travel and accommodation costs were provided by the regulated industry²
3. Within the last three years, grants or other funding from the regulated industry to any of the organizations where you are currently employed or participate in internal decision making³

3. Intellectual interests

1. Within the last five years, any formal advice or opinion to industry, a government organization or a non-government organization on a matter of relevance to the SAC-MET
2. Within the last five years, any published or publicly stated point of view on issues of relevance to the SAC-MET mandate
3. Current professional or volunteer affiliations such as membership of professional societies, lobbying, public interest or advocacy groups, of relevance to the SAC-MET

4. Other

1. Any other affiliations and interests or potential circumstances that might give a well-informed member of the public reasonable grounds for concern regarding the integrity and objectivity of your participation

Biographies and Affiliations and Interests Summaries

Name and Indicated Sector/Perspective and Expertise/Experience		Summary of Response
Peter Walker, MD, FRCPC (Chair)	Health Professional Endocrinology	1a) No	2a) No	2b) No	2c) No	3a) No	3b) No	3c) No	4a) No
		Comments: None
Robert Dent, MD, FRCPC	Academia, Health Professional Internal Medicine	1a) No	2a) Yes	2b) Yes	2c) No	3a) Yes	3b) Yes	3c) Yes	4a) No
		Comments: Speaker for a Panel and received funding from a pharmaceutical company. Travel and accommodations paid by a pharmaceutical company when required to travel internationally. Volunteer for various pharmaceutical companies, Expert panel member on Weight Lost Management and SAC-MET. Has numerous publications and Affiliations with the Canadian Obesity Network.
Colleen Fuller	Patient/Consumer	1a) No	2a) No	2b) No	2c) No	3a) Yes	3b) Yes	3c) Yes	4a) No
		Comments: Member of an Expert Panel, has made numerous presentations to various committees and society's. Is Co-chair of the Society for Diabetic Rights, Chair for Pharma Watch, Member for the Steering Committee of Women & Health Protection, and Member, Board of Directors, REACH Community Health Centre.
Irene Hramiak, MD, FRCPC	Academia Health Professional Endocrinology and Metabolism	1a) No	2a) Yes	2b) No	2c) No	3a) No	3b) No	3c) No	4a) Yes
		Comments: Acts as a consultant on Advisory Boards, receives research funding and honoraria for teaching, speaking or writing from numerous pharmaceutical companies. Is a member of the Ontario Medical Association.
Peter J. McDouglall, CD, BA, MIR, CHRP	Patient/Consumer	1a) No	2a) No	2b) No	2c) No	3a) No	3b) No	3c) No	4a) No
		Comments: None
Ronald Sigal, MD, FRCPC, MPH	Academia Internal Medicine and Endocrinology; Epidemiology	1a) No	2a) Yes	2b) Yes	2c) Yes	3a) Yes	3b) No	3c) Yes	4a) No
		Comments: Is a member of the Canadian Diabetes Association. Received funding for attending advisory board meetings from various pharmaceutical companies (2007 and earlier), and received funding as a principal investigator. Travel and accommodation costs have been paid for travel to a conference by a pharmaceutical company (2007 and earlier). Has received honoraria for a consultation (2008 and ealier).
Ehud Ur, MB, FRCPC	Academia, Health Professional Endocrinology	1a) No	2a) No	2b) Yes	2c) No	3a) No	3b) No	3c) Yes	4a) No
		Comments: He has sat on advisory boards and received travel support from various pharmaceutical companies to attend conferences. He was past Chair for the Canadian Diabetes Association.
George Wells, BSc, MSc, PhD	Academia Epidemiology	1a) No	2a) Yes	2b) No	2c) No	3a) No	3b) No	3c) No	4a) No
		Comments: Provided general health technology presentations for a pharmaceutical company.
Michael Wheeler, BSc, PhD	Research Molecular Biology, Endocrinology and Gasteroenterology	1a) No	2a) Yes	2b) Yes	2c) No	3a) Yes	3b) No	3c) No	4a) No
		Comments: Received a one year grant for laboratory research from a pharmaceutical company. Also receives reimbursement for travel and accommodations when attending scientific meetings organized by the pharmaceutical company. Volunteer for Health Canada's SAC-MET.